regulation of SOX9 transcriptional activity by THRAP3 was mediated by interaction between the proline-, glutamine-, and serine-rich domain of SOX9 and the innominate domain of THRAP3. These results indicate that THRAP3 negatively regulates SOX9 transcriptional activity as a cofactor of a SOX9 transcriptional complex during chondrogenesis.
Introduction
Sex-determining region Y-box (Sox)9 is required during sequential steps of chondrogenesis, mediating chondrocyte proliferation, differentiation, and extracellular matrix production [1, 2] . Sox9 binds to enhancer regions of and directly transactivates Collagen type II alpha I chain (Col2a1), Collagen type XI-alpha II chain (Col11a2), and Aggrecan genes. Mutations in human SOX9 lead to campomelic dysplasia, which is characterized by skeletal malformation and sex reversal [3, 4] .
Several proteins are known to modulate Sox9 transcriptional activity, including Sox5/6, thyroid hormone receptor-associated protein (TRAP)230/Med12, cAMPresponse element-binding protein-binding protein/p300, mothers against decapentaplegic homolog (Smad)3, peroxisome proliferator-activated receptor γ-coactivator (PGC)-1α, protein inhibitor of activated signal transducer and activator of transcription (PIAS) proteins, Tat interactive protein (Tip)60, nuclear RNA-binding protein (p54nrb), Zinc finger protein (Znf)219, AT-rich interactive domain (Arid)5a, and WW domain-containing E3 ubiquitin protein ligase (Wwp)2/Mediator complex subunit (Med)25 [5] [6] [7] [8] [9] [10] [11] [12] [13] [14] . Sox9 induces Sox5 and Sox6
Abstract Sex-determining region Y (Sry)-box (Sox)9 is required for chondrogenesis as a transcriptional activator of genes related to chondrocyte proliferation, differentiation, and cartilage-specific extracellular matrix. Although there have been studies investigating the Sox9-dependent transcriptional complexes, not all their components have been identified. In the present study, we demonstrated that thyroid hormone receptor-associated protein (THRAP)3 is a component of a SOX9 transcriptional complex by liquid chromatography mass spectrometric analysis of FLAG-tagged Sox9-binding proteins purified from FLAG-HA-tagged Sox9 knock-in mice. Thrap3 knockdown in ATDC5 chondrogenic cells increased the expression of Collagen type II alpha 1 chain (Col2a1) without affecting Sox9 expression. THRAP3 and SOX9 overexpression reduced Col2a1 levels to a greater degree than overexpression of SOX9 alone. The negative transcription, and the three proteins cooperatively regulate the expression of cartilage-specific extracellular matrix genes [1, [15] [16] [17] [18] . Tip60 and PIAS were identified by yeast-two-hybrid screening and found to modulate Sox9 transcriptional activity by modifying Sox9. Arid5a, which was identified in a Col2a1 promoter reporter assay as a transcriptional partner of Sox9, regulates chondrocyte differentiation by inducing histone H3 acetylation of chondrocyte-specific genes. Smad3 and PGC-1α regulate Col2a1 expression by associating with Sox9 and p300; the latter stimulates Sox9-dependent transcription by modifying histone acetylation. p54nrb and Sox9 interact to regulate paraspeckle formation and mRNA processing, which are necessary for chondrocyte differentiation. In contrast, Trap230, a member of the TRAP complex, directly binds Sox9 and may interfere with the ability of T-cell and lymphoid enhancer-binding factors to bind β-catenin, thereby modulating Wnt signaling. Znf219 may function as an adaptor protein to recruit Sox9-binding partners. Med25, a component of the Mediator transcriptional coactivator complex, binds to and positively regulates Sox9 transcriptional activity in a Wwp2-dependent manner.
To identify the components of the SOX9 transcriptional complex during chondrogenesis, we generated FLAG-HA-tagged Sox9 knock-in mice expressing FLAG-tagged Sox9 protein and identified a group of proteins that bind to Sox9 in chondrocytes in vivo by immunoprecipitation and liquid chromatography-tandem mass spectrometry (LC-MS/MS). One of these, thyroid hormone receptor-associated protein (Thrap)3/ TRAP150, is a multifunctional polypeptide and minor component of the TRAP/Mediator complex that communicates regulatory signals from DNA-bound transcription factors to RNA polymerase II. It was previously reported that nuclear thyroid hormone receptor interactor 6 homodimers mediate the promoter recruitment of THRAP3, which acts as a co-activator for activator protein-1 [19] . Circadian-dependent Thrap3 was found to promote DNA binding of the CLOCK-Brain and muscle aryl hydrocarbon receptor nuclear translocator-like protein 1 complex and its association with basic transcriptional machinery [20] . THRAP3 was found to directly bind helicase motifs in helicase with zinc finger 2β as an adaptor molecule for other transcriptional coregulators to enhance peroxisome proliferator-activated receptor (PPAR)γ-mediated gene activation [21] . In addition to its role in transcriptional regulation, THRAP3 is involved in precursor-mRNA alternative splicing [22] and the DNA damage response [23] . In the present study, we demonstrate that THRAP3 interacts physically with SOX9 to negatively regulate its transcriptional activity in chondrogenesis.
Materials and methods

Generation of mutant mice
FLAG-HA-tagged Sox9 knock-in mice were generated using a targeting vector spanning a 13-kb fragment of the 129SvEv mouse Sox9 gene. FLAG and HA tags were introduced immediately downstream of the first ATG of exon 1 of Sox9, and a loxP-flanked PGK-neo-bpA cassette was introduced into intron 1. The targeting vector was introduced into AB-1 embryonic stem (ES) cells [24] . Mouse chimeras were generated by injecting mutant ES cell clones into C57BL/6J host blastocysts and were bred with C57BL/6J mice to obtain FLAG-HA-tagged Sox9 knock-in heterozygous mice, which were confirmed by Southern blotting. Animal care and experimental procedures were approved by the Animal Research Committee of Kyoto University, and were in accordance with the Regulations on Animal Experimentation of Kyoto University.
Cell culture
Primary chondrocytes were isolated from the costal cartilage of neonatal FLAG-HA-tagged Sox9 knock-in pups. Minced cartilage was incubated with a trypsin-EDTA solution (Sigma-Aldrich, St. Louis, MO, USA) at 37 °C for 25 min and subsequently digested with medium containing collagenase type 2 [1.5 × 10 4 U; Worthington Biochemical, Lakewood, NJ, USA] at 37 °C for 3 h. Chondrocytes were grown in Dulbecco's modified Eagle's medium (DMEM) (SigmaAldrich) supplemented with 10% fetal bovine serum (FBS) (PAA Laboratories/GE Healthcare, Chicago, IL, USA) and 1% penicillin-streptomycin (Sigma-Aldrich) at 37 °C in a humidified atmosphere of 5% CO 2 and 95% air. The culture medium was replaced every other day.
ATDC5 cells were cultured as previously described [25, 26] . Briefly, cells were maintained in log-growth phase in a 1:1 mixture of DMEM/Ham's F-12 medium (Corning, Corning, NY, USA) containing 5% FBS (Cambrex, Charles City, IA, USA), 10 μg/ml human transferrin (Wako, Osaka, Japan), and 3 × 10 −8 M sodium selenite (Sigma-Aldrich) (maintenance medium) at 37 °C in a humidified atmosphere of 5% CO 2 /95% air. Chondrogenesis was induced in maintenance medium supplemented with 10 μg/ml bovine insulin (Wako) (differentiation medium). C3H10T1/2 [27] and HEK 293 [28] cells were grown in DMEM (Sigma-Aldrich) containing 10% FBS and 1% penicillin-streptomycin.
Plasmids
The pENTR221 human THRAP3 vector was purchased from DNAFORM (Yokohama, Japan). cDNA sequences encoding full-length and truncated human THRAP3 were amplified using specific primers and inserted into pcDNA3.1 V5 His TOPO vectors (Thermo Fischer, Waltham, MA, USA). FLAG-tagged full-length and truncated human SOX9 expression vectors were generated as previously described [2] .
Preparation of whole-cell lysates
Proteins were extracted from ATDC5 cells and C3H10T1/2 cells using cold radioimmunoprecipitation assay (RIPA) lysis buffer with protease inhibitor cocktail (Sigma-Aldrich).
Liquid chromatography-tandem mass spectrometry (LC-MS/MS)
Whole-cell lysates of primary chondrocytes derived from costal cartilage of neonatal FLAG-HA-tagged Sox9 knock-in mice were prepared in 50 mM Tris-HCl (pH 7.9), 200 mM NaCl, 1% NP-40, and complete protease inhibitor mixture (Roche Applied Science); 150 mg protein from the lysates was subjected to immunoprecipitation with anti-FLAG M2 antibody-conjugated agarose affinity gel (Sigma-Aldrich) overnight at 4 °C. After washing, bound proteins were eluted with excess amounts of FLAG peptide (Sigma-Aldrich) and resolved by sodium dodecyl sulfate-polyacrylamide gel electrophoresis (SDS-PAGE). To visualize the purified proteins, the gel was stained with silver nitrate [29] . To identify the proteins, the gel was stained with imidazole-zinc method [30] , and bands were excised and analyzed by LC-MS/MS.
Western blotting
Costal cartilage of neonatal FLAG-HA-tagged Sox9 knockin mice was homogenized in RIPA lysis buffer; proteins were separated by SDS-PAGE and transferred to a polyvinylidene difluoride membrane that was blocked with 5% skim milk in Tris-buffered saline with 0.1% Tween-20 for 30 min at room temperature. The membrane was incubated overnight at 4 °C with rabbit anti-Sox9 (1:2000; Merck Millipore) and peroxidase-conjugated anti-FLAG M2 (1:3000; Sigma-Aldrich) antibodies. Immunoreactivity was detected using horseradish peroxidase (HRP)-conjugated swine anti-rabbit antibody (Dako, Carpinteria, CA, USA) diluted 1:3000 and enhanced chemiluminescence (ECL) substrate (Thermo Fisher).
Short interfering (si)RNA and gene transfection
ATDC5 cells were transfected with siRNA specific for mouse Thrap3 (MISSION siRNA; Sigma-Aldrich) using Lipofectamine 2000 (Thermo Fisher) and with V5-tagged THRAP3 expression plasmids using Lipofectamine LTX (Thermo Fisher) according to the manufacturer's protocols. Total RNA was extracted 48 h later, and 100 ng total RNA was used to synthesize cDNA with ReverTra Ace (Toyobo, Osaka, Japan). Quantitative real-time polymerase chain reaction (PCR) was performed on a Light Cycler instrument (Roche Diagnostics, Indianapolis, IN, USA) with Thunderbird SYBR qPCR mix (Toyobo). Sequences of primers used for PCR are shown in Table 1 . 
Luciferase assay
A chondrocyte-specific p89/4 × 48 Col2a1 reporter construct was used as previously described [14] , with pcDNA-Renilla luciferase as an internal control. HEK293 cells were transfected with the plasmids using FuGENE HD reagent (Roche Diagnostics). Luciferase activity was assayed 48 h later.
Immunoprecipitation
C3H10T1/2 cells were transfected with tagged plasmids using the FuGENE HD transfection reagent (Roche Diagnostics); 24 h later, cells were lysed in buffer composed of 50 mM Tris, 150 mM NaCl, 1 mM EDTA, and 1% Triton X-100. Protein complexes were precleared with 40 µl protein G Sepharose (GE Healthcare) for 1 h and immunoprecipitated overnight at 4 °C using 60 μl EZview Red FLAG M2 Affinity Gel (Sigma-Aldrich), 60 μl agarose-conjugated anti-V5 tag polyclonal antibody (Medical and Biological Laboratories, Nagoya, Japan), and 60 μl protein G agarose (Thermo Fisher) with 4 µg rabbit anti-mouse IgG (2.5 mg ml −1 ; Cell Signaling Technology, Danvers, MA, USA). Immunoprecipitated proteins were detected by immunoblotting using HRP-conjugated mouse anti-V5 (1:5000; Invitrogen) and peroxidase-conjugated mouse anti-FLAG M2 (1:3000; Sigma-Aldrich) antibodies and visualized by ECL.
Chromatin immunoprecipitation (ChIP) assay
ChIP was performed using a kit (Abcam, Cambridge, UK) according to the manufacturer's protocol. Briefly, primary chondrocytes obtained from FLAG-HA-tagged Sox9 knockin pups were cultured in a 100-mm dish, and cross-linked chromatin fragments were immunoprecipitated using 40 μl protein G agarose, 4 µg rabbit anti-mouse IgG (Cell Signaling Genomic DNA isolated from ES cell clones was digested with BamHI and then hybridized with the 3′-probe. The wild-type and mutant alleles were detected as 13.0-kb and 11.5-kb bands, respectively. c Rib cartilages of neonatal wildtype pups or FLAG-HA-tagged Sox9 knock-in pups were lysed in RIPA buffer, and proteins were analyzed by Western blotting using anti-Sox9 and anti-FLAG antibody. d Comparison between 4-weekold FLAG-HA-tagged Sox9 knock-in homozygous mouse and a wildtype mouse. No phenotypic differences were observed. e Rib chondrocytes of FLAG-HA tagged Sox9 knock-in pups were incubated and proteins of these cells were analyzed by ChIP assay. Recruitment of Sox9 and FLAG to the chondrocyte-specific enhancer region of the Col2a1 gene was detected. Sox9-FLAG fusion proteins were successfully formed in vivo Technology), and 4 µg anti-Sox9 antibody or 40 μl EZview Red FLAG M2 Affinity Gel. Coprecipitation of the Col2a1 enhancer region was detected by PCR [14] . C3H10T1/2 cells cultured in 100-mm dishes were cotransfected with FLAGtagged SOX9 and V5-tagged THRAP3 expression vectors. After 24 h, cross-linked chromatin fragments were immunoprecipitated with 4 µg anti-Sox9 antibody and 40 μl agaroseconjugated anti-V5 tag polyclonal antibody. Coprecipitation of the Col2a1 enhancer region and the Col11a1 promoter region were detected by PCR (Table 1 ) [14] .
Immunohistochemical analysis
Limb buds of embryonic day 16.5 C57BL/6 J mouse embryos were fixed in 4% paraformaldehyde, dehydrated, and embedded in paraffin. Sections were cut at a thickness of 5 μm and stained with hematoxylin and eosin. Immunohistochemical analysis was carried out using SuperPicture HRP polymer conjugate diaminobenzidine (rabbit; Thermo Fisher), with hematoxylin used as a counterstain. We used anti-Sox9 and rabbit polyclonal anti-TRAP150 antibodies (Santa Cruz Biotechnology, Santa Cruz, CA, USA) diluted 1:500 and 1:50, respectively, in Antibody Diluent Reagent Solution (Thermo Fisher).
Immunofluorescence analysis
ATDC5 cells were fixed with 10% formaldehyde for 12 min at room temperature. After washing, cells were blocked with fresh blocking solution composed of 4% donkey serum in phosphate-buffered saline (PBS) containing 0.1% Triton X-100 (PBST; Sigma-Aldrich) for 30 min and then incubated for 1 h at room temperature with rabbit polyclonal anti-TRAP150 antibodies diluted 1:50 in 1% bovine serum/PBST. Cells were washed and incubated for 1 h at room temperature with Alexa Fluor 555-conjugated donkey anti-rabbit IgG (Abcam) diluted 1:1000. The procedure was repeated using a mouse anti-Sox9 antibody Alexa Fluor 488 (Santa Cruz Biotechnology) diluted 1:50. Nuclei were counterstained with 300 nM DAPI (Thermo Fisher). Images were acquired on a fluorescence microscope (Keyence, Osaka, Japan). Transfected ATDC5 cells were fixed, blocked, and then incubated for 1 h at room temperature with anti-Sox9 antibody diluted Fig. 2 Silver stain of FLAG-tagged Sox9 fusion proteins. a FLAGtagged Sox9 fusion proteins from rib cartilages of FLAG-HA-tagged Sox9 knock-in pups were purified by FLAG beads. Eluents were then electrophoresed and stained. There were several bands around 1:200 in 1% donkey serum/PBST. Cells were washed and incubated for 1 h at room temperature with Alexa Fluor 555-conjugated donkey anti-rabbit IgG (Abcam) diluted 1:1000. The procedure was repeated using a goat anti-V5 antibody (Abcam) diluted 1:200 and Alexa Fluor 488-conjugated donkey anti-goat IgG (Abcam) diluted 1:1000. Nuclei were counterstained with TO-PRO-3 (Thermo Fisher) diluted 1:3000. Images were acquired on a confocal laser microscope (Nikon Instruments, Tokyo, Japan).
Results
Generation of FLAG-HA tagged Sox9 knock-in mice
We generated mutant mice in which FLAG and HA tags were inserted into exon 1 of the Sox9 gene by gene targeting in ES cells (Fig. 1a) . Southern blot analysis of genomic DNA purified from recombinant ES cell clones revealed an 11.5-kb fragment corresponding to the mutant allele following digestion by BamHI (Fig. 1b) .
We also analyzed FLAG-tagged Sox9 purified from the rib cage of neonatal FLAG-HA-tagged Sox9 knock-in mice by Western blot analysis (Fig. 1c) . Hetero-and homozygous mutant mice were viable and fertile and showed no apparent phenotypic changes compared to controls (Fig. 1d) , suggesting that the tagged Sox9 protein worked efficiently in vivo. ChIP using chondrocytes from FLAG-HA-tagged Sox9 knock-in mice revealed specific binding of FLAG-tagged Sox9 protein to the Col2a1 enhancer region (Fig. 1e) .
Purification of Sox9 transcriptional complex
Proteins in whole-cell lysates from the costal cartilage of neonatal FLAG-HA-tagged Sox9 knock-in pups were immunoprecipitated using FLAG-M2 beads. The eluents were analyzed by gel electrophoresis and silver staining (Fig. 2a) . A mass spectrometry analysis of the bands identified 24 transcriptional proteins associated with Sox9 ( Fig. 2b; Table 2 ). We focused our analysis on Thrap3, which was present around 150 kDa.
Thrap3 modulates Sox9 transcription of Col2a1
We analyzed the expression of Sox9, Col2a1, Col11a1, and Thrap3 in chondrogenesis using ATDC5 cells. Sox9 levels increased during the first 7 days of culture and then remained constant (Fig. 3a) . Thrap3 levels reached a peak on day 10 and decreased thereafter. Col2a1 levels gradually increased and reached a plateau after 3 weeks. Col11a1 levels reached a peak on day 14 and decreased thereafter (Table 1) .
Thrap3 expression was silenced by siRNA in ATDC5 cells (Fig. 3b) . Thrap3 knockdown increased Col2a1 expression without altering Sox9 levels. In addition, overexpression of SOX9 stimulated Col2a1 expression, whereas THRAP3 overexpression had no effect (Fig. 3c) . Cotransfection of THRAP3 and SOX9 abolished the increase in Col2a1 expression induced by SOX9.
A luciferase reporter assay in HEK293 cells using the p89/4 × 48 Col2a1 plasmid showed that cotransfection of SOX9 and THRAP3 reduced reporter activity as compared to transfection of SOX9 alone (Fig. 3d ).
THRAP3 colocalizes with SOX9 in chondrocytes in the growth plate and in ATDC5 cells
The humerus of a wild-type mouse was sectioned and labeled with anti-Sox9 or Thrap3 antibody. Both Sox9 and Thrap3 were expressed in the nuclei of proliferating and prehypertrophic chondrocytes (Fig. 4a) . To observe the subcellular localization of Thrap3, protein localization in ATDC5 cells was evaluated by immunofluorescence microscopy. Sox9 and Thrap3 immunoreactivities were detected in the Table 2 Transcriptional proteins associated with Sox9 detected by liquid chromatography-tandem mass spectrometry (LC-MS/MS) Acidic nuclear phosphoprotein 32 family member B Activated RNA polymerase II transcriptional coactivator p15 Chain A, X-ray structure of Nm23 human nucleoside diphosphate kinase B General transcription factor IIIC polypeptide 5 General transcription factor IIIC, polypeptide 5 isoform 3 Heterogeneous nuclear ribonucleoprotein U High mobility group protein B1 Histone-binding protein retinoblastoma-binding protein 7 Nascent polypeptide-associated complex alpha polypeptide Ngg1 interacting factor 3-like 1 Nucleoside-diphosphate kinase B Nucleosome assembly protein 1-like 1 Per1 protein Polymerase I and transcript release factor Prohibitin Prohibitin 2 Protein arginine N-methyltransferase 5 isoform 1 Purine-rich element-binding protein B Putative HLA DR-associated protein II RNA-binding protein 3 Staphylococcal nuclease domain-containing protein 1 Thyroid hormone receptor-associated protein 3 (Thrap3) Transcription intermediary factor 1-beta V-rel reticuloendotheliosis viral oncogene homolog nucleus (Fig. 4b, c) , suggesting that they may interact to regulate transcription.
THRAP3 interacts with SOX9
To determine whether SOX9 and THRAP3 physically interact, we performed co-immunoprecipitation of C3H10T1/2 cells cotransfected with FLAG-tagged SOX9 and V5-tagged THRAP3. We found that THRAP3 physically interacted with SOX9 (Fig. 5a) . Similar experiments using deletion mutations of SOX9 (Fig. 5b) and THRAP3 (Fig. 5d) showed that this interaction was mediated by the proline-, glutamine-, and serine-rich domain of SOX9 (Fig. 5c) and by the innominate domain of THRAP3 (Fig. 5e) . ChIP using C3H10T1/2 cells cotransfected with FLAG-tagged SOX9 and V5-tagged THRAP3 revealed specific binding of both THRAP3 and SOX9 to the Col2a1 enhancer region and to the Col11a1 promoter region (Fig. 5f) . A luciferase reporter assay in HEK293 cells using the p89/4 × 48 Col2a1 plasmid showed that cotransfection of SOX9 and C-terminus-deleted THRAP3 vector (1-597) reduced reporter activity as compared to transfection of SOX9 alone. Cotransfection of SOX9 and N-terminus of THRAP3 vector (1-164) did not show significant change in reporter activity compared with SOX9 alone (Fig. 5g) .
Discussion
In this study, we identified THRAP3 as a component of the SOX9 transcriptional complex in chondrocytes by LC-MS/ MS analysis of proteins that coprecipitated with Sox9 from FLAG-HA-tagged Sox9 knock-in mice. We confirmed that THRAP3 suppressed SOX9 transcriptional activity, whereas Thrap3 knockdown increased the expression of the Col2a1 gene. We also demonstrated by a co-immunoprecipitation assay that THRAP3 directly interacts with SOX9. Our results suggest that THRAP3 modulates SOX9 transcriptional activity in chondrocytes as a factor in the transcriptional complex.
Previous studies on the Sox9 transcriptional complex during chondrogenesis have mostly analyzed chondrocyte-specific gene rather than protein expression. Here we purified the SOX9 transcriptional complex from FLAG-HA-tagged Sox9 knock-in mice, which is a more physiologically relevant approach than in vitro methods. Sox9 is an essential transcriptional factor in testicular formation, and binding of Nuclear receptor subfamily 5 group A member 1 and Sry to the testis-specific enhancer core element (TESCO) is required for Sox9 transcription [31] . On the other hand, in the ovaries, Forkhead box L2 binds to TESCO to suppress enhancer activity [32] . Wnt4 was found to block Sox9 expression via activation of β-catenin [33] , which is in accordance with our previous report that β-catenin inhibited Col2a1 reporter activity via inhibition of Sox9 [2] . THRAP3 activity is similar to that of β-catenin in that both proteins inhibit Col2a1 expression. In resting T cells, glycogen synthase kinase phosphorylates the DNA/RNA-binding protein polypyrimidine tract-binding protein-associated splicing factor and interacts with THRAP3 to block cluster of differentiation 45 exon skipping [34] . These findings imply that THRAP3 plays an indirect role in WNT signaling.
Smad nuclear interacting protein (SNIP)1 is a regulator of Cyclin D1 expression; THRAP3 was identified as a component of the SNIP1/SKI-interacting protein-associated RNA processing complex, which contributes to posttranscriptional cyclin D1 mRNA stability [35] . Wilms' tumor 1-associating protein (WTAP) mediates G2/M transition by stabilizing Cyclin A2 mRNA and was found to be associated with THRAP3 in human umbilical vein endothelial cells. Double knockdown of THRAP3 and B-cell lymphoma 2-associated transcription factor 1 increased WTAP protein expression [36] , demonstrating that THRAP3 is a component of the cell cycle-related gene expression complex. In addition, arraybased comparative genomic hybridization analyses have revealed THRAP3 deficiency in oral squamous cell carcinoma [37] , and whole-genome sequencing analyses have detected somatic point mutations in the THRAP3 gene in parathyroid carcinoma tissues as well as addition of intronic sequences to exons during splicing of the THRAP3 gene in liver cancer [38] . THRAP3 phosphorylation may be associated with androgen-independent prostate cancer cell growth [39] . In mesenchymal cell lineages, THRAP3 was found to interact with PPARγ and activate diabetes-associated genes in adipocytes [21] . Ours is the first report of a role for THRAP3 in chondrogenesis; we demonstrated that Thrap3 knockdown and overexpression stimulated and inhibited chondrogenesis, respectively, which involved the regulation of Sox9 transcriptional activity by THRAP3 in Col2a1 transcription.
In preliminary experiments, we observed that thrap3b knockdown in zebrafish resulted in the abnormal somitogenesis and head formation, although thrap3a knockdown and overexpression had no effect on somitogenesis, chondrogenesis, or development (data not shown). However, loss of the WTAP complex resulted in Cyclin A2 mRNA destabilization and embryonic lethality in the mouse [40] . Further study is needed to clarify the role of THRAP3 in somitogenesis. In conclusion, THRAP3 interacts with and inhibits the transcriptional activity of SOX9 during chondrogenesis. Our results provide insight into the mechanism underlying chondrocyte generation, which can serve as a basis for the development of therapeutic strategies to treat cartilage disorders.
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Fig. 5 THRAP3 interacts physically with SOX9 and regulates
Sox9 transcriptonal activity. a Co-immunoprecipitation indicates that THRAP3 interacts physically with SOX9 in C3H10T1/2 cells. In the left lane, we used proteins from C3H10T1/2 cells into which V5-tagged THRAP3 and empty vector were transfected. In the right lane, we used proteins from C3H10T1/2 cells into which V5-tagged THRAP3 and FLAG-tagged SOX9 vector were transfected. b Schematic images of SOX9 deletion mutants. SOX9 contains a high-mobility group domain (HMG, residues 104-182); a proline, glutamine, and alanine domain (P QA, residues 339-379); and a proline-, glutamine-, and serine-rich domain (PQS-rich, residues 402-509). c Co-immunoprecipitation assays between V5-tagged THRAP3 and FLAG-tagged SOX9 and deletion mutants. d Schematic images of THRAP3 deletion mutants. THRAP3 contains a serinearginine-rich domain (SR, residues 1-164); and homologous domain to a BCL-2 associated transcription factor 1 (BCLAF1, residues 597-955). e Co-immunoprecipitation assays between FLAG-tagged SOX9 and V5-tagged THRAP3 and deletion mutants. f ChIP assay detected recruitment of SOX9 and THRAP3 to the chondrocytespecific enhancer region of the Col2a1 gene and to the promoter region of the Col11a1 gene. Cell lysate extracted from C3H10T1/2 cells that were cotransfected with FLAG-tagged SOX9 and V5-tagged THRAP3 was immunoprecipitated with anti-SOX9 antibody or anti-V5 tag antibody. g Luciferase reporter assay using the p89/4 × 48 Col2a1 reporter plasmid in HEK293 cells. Activation of the reporter construct by SOX9 was inhibited by C-terminus-deleted THRAP3 . N-terminus THRAP3 (1-164) did not affect the reporter activity (mean + SD; Tukey-Kramer's test, *p < 0.05, ***p < 0.001; n = 3)
